LUP Statistics
Record
- Title
- RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- Type
- Journal Article
- Publ. year
- 2017
- Author/s
- Westborg, Inger; Albrecht, Susanne; Rosso, Aldana
- Department/s
- Radiology Diagnostics, Malmö
- In LUP since
- 2017-02-14
Downloads
| Total | This Year | This Month |
| 383 | 13 | 0 |
United States of America  |
247 (64%) |
Germany  |
31 (8%) |
Sweden  |
19 (5%) |
China  |
17 (4%) |
United Kingdom of Great Britain and Northern Ireland  |
15 (4%) |
France  |
7 (2%) |
Australia  |
6 (2%) |
Canada  |
5 (1%) |
Netherlands (Kingdom of the)  |
5 (1%) |
Italy  |
4 (1%) |
Denmark  |
3 (1%) |
Portugal  |
3 (1%) |
Egypt  |
2 (1%) |
Finland  |
2 (1%) |
Brazil  |
2 (1%) |
Romania  |
1 (0%) |
Hong Kong (China)  |
1 (0%) |
Estonia  |
1 (0%) |
India  |
1 (0%) |
Lithuania  |
1 (0%) |
Ireland  |
1 (0%) |
Spain  |
1 (0%) |
Singapore  |
1 (0%) |
Taiwan (China)  |
1 (0%) |
Mexico  |
1 (0%) |
Unknown  |
1 (0%) |
New Zealand  |
1 (0%) |
Philippines  |
1 (0%) |
Poland  |
1 (0%) |
Indonesia  |
1 (0%) |